Royal Bank of Canada’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15K | Hold |
2,125
| – | – | ﹤0.01% | 5968 |
|
|
2025
Q1 | $18K | Sell |
2,125
-20,883
| -91% | -$177K | ﹤0.01% | 5565 |
|
|
2024
Q4 | $916K | Buy |
+23,008
| New | +$916K | ﹤0.01% | 3199 |
|
|
2024
Q3 | – | Sell |
-20
| Closed | – | – | 6326 |
|
|
2024
Q2 | $0 | Buy |
20
+15
| +300% | – | ﹤0.01% | 6590 |
|
|
2024
Q1 | $0 | Sell |
5
-13
| -72% | – | ﹤0.01% | 6505 |
|
|
2023
Q4 | $0 | Sell |
18
-25,764
| -100% | – | ﹤0.01% | 6523 |
|
|
2023
Q3 | $481K | Sell |
25,782
-7,834
| -23% | -$146K | ﹤0.01% | 3603 |
|
|
2023
Q2 | $816K | Buy |
33,616
+31,827
| +1,779% | +$773K | ﹤0.01% | 3166 |
|
|
2023
Q1 | $39K | Buy |
1,789
+1,788
| +178,800% | +$39K | ﹤0.01% | 5365 |
|
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 6701 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 6908 |
|
|
2022
Q2 | $0 | Sell |
1
-51
| -98% | – | ﹤0.01% | 6857 |
|
|
2022
Q1 | $3K | Sell |
52
-122
| -70% | -$7.04K | ﹤0.01% | 6882 |
|
|
2021
Q4 | $52K | Buy |
174
+103
| +145% | +$30.8K | ﹤0.01% | 5819 |
|
|
2021
Q3 | $27K | Buy |
71
+20
| +39% | +$7.61K | ﹤0.01% | 5990 |
|
|
2021
Q2 | $26K | Buy |
51
+26
| +104% | +$13.3K | ﹤0.01% | 5913 |
|
|
2021
Q1 | $14K | Buy |
25
+3
| +14% | +$1.68K | ﹤0.01% | 6125 |
|
|
2020
Q4 | $15K | Buy |
+22
| New | +$15K | ﹤0.01% | 5631 |
|